<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04028583</url>
  </required_header>
  <id_info>
    <org_study_id>TaIPE</org_study_id>
    <nct_id>NCT04028583</nct_id>
  </id_info>
  <brief_title>Tool for Inappropriate Prescription Evaluation: The TaIPE Study</brief_title>
  <acronym>TaIPE</acronym>
  <official_title>Tool for Inappropriate Prescription Evaluation: The TaIPE Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A mono-center, randomized controlled trial will be conducted at the University Hospital of
      Lausanne. Hospitalized patients will be randomly assigned from the emergency department to
      two sub-units composing the acute care for elders (ACE) unit. In one subunit, potentially
      inappropriate prescriptions will be detected and treatment optimized according PIM-Check. In
      the other, STOPP/START criteria will be independently applied.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 26, 2018</start_date>
  <completion_date type="Anticipated">August 4, 2019</completion_date>
  <primary_completion_date type="Actual">April 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Potentially Inappropriate Prescriptions (PIPs) reduction in the PIM-Check group compared to STOPP/START</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number and type of PIPs detected by each tool</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of acceptability</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of treatment (mean and median) modification by clinicians</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of drugs at discharge</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence rate of falls</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activities of daily living (ADL) score</measure>
    <time_frame>18 months</time_frame>
    <description>Activities of daily living are routine activities people do every day without assistance (6 basic activities) : eating, bathing, getting dressed, toileting, transferring, and continence. The score is the number of activities performed without assistance. Score ranges : from 0/6 (minimum) to 6/6 (maximum). Higher values represent a better outcome of activities of daily living.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Confusion Assessment Method (CAM)</measure>
    <time_frame>18 months</time_frame>
    <description>Result ranges : [negative result (-) = no confusion] ; [positive result (+) = confusion].</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of unplanned readmission</measure>
    <time_frame>up to 3 months after discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between the number and type of PIPs at discharge with rate of re-admission</measure>
    <time_frame>up to 3 months after discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">464</enrollment>
  <condition>Inappropriate Prescribing</condition>
  <arm_group>
    <arm_group_label>PIM-Check group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>STOPP/START group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PIM-Check</intervention_name>
    <description>In the PIM-Check group, a medication review will be conducted using PIM-Check within 72 hours of patient's admittance to the unit. The physician will decide whether to accept these recommendations or not and implement prescribing changes if agreed.</description>
    <arm_group_label>PIM-Check group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>STOPP/START</intervention_name>
    <description>In the STOPP/START group, medication lists will be analyzed within 72 hours of patient's admittance and optimized according to STOPP/START criteria. The second physician will decide whether to accept these recommendations or not and implement prescribing changes if agreed.</description>
    <arm_group_label>STOPP/START group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients meeting the admission criteria of the acute care for elders (ACE) unit
             will be eligible.

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chantal Csajka, PharmD, PhD</last_name>
    <phone>+41 21 314 42 63</phone>
    <email>chantal.csajka@chuv.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Akram FARHAT, PharmD, MPH, PhD</last_name>
    <email>akram.farhat@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Akram FARHAT, PharmD, MPH, PhD</last_name>
      <email>akram.farhat@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Chantal Csajka, PharmD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre-Olivier Lang, MPH, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Akram FARHAT, PharmD, MPH, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 17, 2019</study_first_submitted>
  <study_first_submitted_qc>July 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2019</study_first_posted>
  <last_update_submitted>July 22, 2019</last_update_submitted>
  <last_update_submitted_qc>July 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>Chantal Csajka</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Inappropriate Prescribing</keyword>
  <keyword>Potentially Inappropriate Medication List</keyword>
  <keyword>Aged</keyword>
  <keyword>Practice Guideline</keyword>
  <keyword>Education, Medical</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

